What is colorectal adenocarcinoma?

In general, surgery is the optimal treatment for colon cancer. After surgery, patients must receive diligent postoperative care and recuperation. It is also essential to remain vigilant for disease recurrence and to prevent tumor metastasis; once recurrence or metastasis occurs, treatment becomes significantly more challenging. So, what exactly is colonic adenocarcinoma? The following section addresses this question.

What Is Colonic Adenocarcinoma?

Colonic adenocarcinoma is the most common histopathological subtype of colon cancer. Microscopically, it typically exhibits either polypoid or ulcerative growth patterns. In its early stages, it often produces no distinct clinical symptoms. As the disease progresses, patients may gradually develop alterations in bowel habits and stool characteristics, as well as abdominal pain, hematochezia (rectal bleeding), or purulent bloody stools.

Once a definitive diagnosis of colorectal cancer is established, surgical resection is generally recommended for early-stage disease. Following surgery, adjuvant radiotherapy and/or chemotherapy may be advised based on pathological staging and risk assessment. The primary goals of such adjuvant therapies are to prolong survival and reduce the risk of recurrence.

However, some patients respond poorly to treatment and may experience rapid recurrence or metastasis within a short timeframe, resulting in relatively shorter survival durations. Moreover, certain patients with colonic adenocarcinoma are diagnosed at an advanced stage, rendering them ineligible for curative surgery. For these individuals, the therapeutic objectives shift toward symptom palliation, survival extension, and improvement in quality of life.

We hope the above information is helpful to you.